A traditional Chinese medicine composition for improving atrophic gastritis and its preparation method
By using a combination of Chinese herbs such as Codonopsis pilosula to regulate spleen and stomach function, this method solves the problems of simplistic formulation and poor efficacy of existing Chinese medicine prescriptions in improving chronic atrophic gastritis, and achieves significant effects in gastric mucosal repair and gastric motility restoration.
Patent Information
- Application Number
- CN202610877845.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-06-17
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2046-06-17
AI Technical Summary
Existing traditional Chinese medicine formulas for improving chronic atrophic gastritis are not concise enough in their formulation and lack strong targeting. They also do not have a significant effect on reversing atrophy of gastric mucosal glands. Western medicine treatments have problems with adverse reactions and drug resistance.
This preparation uses a combination of traditional Chinese medicine ingredients, including Codonopsis pilosula, stir-fried Atractylodes macrocephala, Dendrobium nobile, Poria cocos, Angelica dahurica, Amomum villosum, Auricularia auricula-judae, Amomum cardamomum, and Glycyrrhiza uralensis, and is made through decoction, filtration, and concentration to regulate spleen and stomach function and promote gastric mucosal repair.
It significantly improves the symptoms of chronic atrophic gastritis, increases gastric mucosal blood flow, restores gastric motility, reduces inflammatory response, regulates gastric mucosal blood flow, and has good safety.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a traditional Chinese medicine composition for improving atrophic gastritis and its preparation method. Background Technology
[0002] Chronic atrophic gastritis is a common chronic digestive disease in clinical practice. Its core pathological feature is atrophy and reduction in the number of gastric mucosal glands. It is often accompanied by intestinal metaplasia, pseudopyloric metaplasia and dysplasia. It is listed by the World Health Organization as a precancerous lesion and seriously threatens the health and quality of life of patients.
[0003] Currently, Western medicine treatment for chronic atrophic gastritis mainly involves symptomatic treatments such as eradicating Helicobacter pylori, supplementing with folic acid and antioxidant vitamins, and using gastric mucosal protectants and prokinetic drugs. However, these methods have limited effectiveness in reversing existing gastric mucosal glandular atrophy and intestinal metaplasia, and long-term medication has certain adverse reactions and drug resistance issues. There is still a lack of specific drugs that can effectively reverse the pathological changes in the gastric mucosa.
[0004] Traditional Chinese medicine (TCM) has a long history and rich experience in the diagnosis and treatment of spleen and stomach diseases. Following the principles of holistic treatment and syndrome differentiation, it formulates prescriptions and uses medications from the perspectives of invigorating qi and strengthening the spleen, nourishing yin and benefiting the stomach, resolving dampness and clearing heat, and unblocking meridians and relieving pain. This multi-target and multi-link regulation of bodily functions promotes gastric mucosal repair and improves clinical symptoms and pathological conditions, demonstrating unique advantages and promising application prospects in the treatment of chronic atrophic gastritis (CAG). In recent years, various TCM compound prescriptions or prepared medicines have been reported to improve symptoms and gastric mucosal pathological conditions associated with CAG. For example, the Sijunzi Decoction, based on herbs such as Codonopsis pilosula, Atractylodes macrocephala, Poria cocos, and Glycyrrhiza uralensis, improves spleen and stomach weakness by invigorating qi and strengthening the spleen; it is combined with yin-nourishing herbs such as Dendrobium nobile, Ophiopogon japonicus, and Adenophora stricta to nourish stomach yin; or it adds heat-clearing, detoxifying, blood-activating, and stasis-removing herbs such as Scutellaria barbata, Hedyotis diffusa, and Salvia miltiorrhiza to intervene in intestinal metaplasia and dysplasia. However, existing traditional Chinese medicine formulas or compositions suffer from problems such as insufficiently refined formulation, weak targeting, and limited effectiveness in reversing gastric mucosal glandular atrophy, resulting in inconsistent clinical efficacy. Therefore, developing a traditional Chinese medicine composition with definite efficacy and high safety that can effectively improve chronic atrophic gastritis has significant clinical value and practical implications. Summary of the Invention
[0005] The primary objective of this invention is to provide a traditional Chinese medicine composition for improving atrophic gastritis.
[0006] The second objective of this invention is to provide a method for preparing a traditional Chinese medicine composition for improving atrophic gastritis.
[0007] To achieve the above objectives, the technical solution adopted by the present invention is as follows: A traditional Chinese medicine composition for improving atrophic gastritis, comprising the following raw materials in parts by weight: Codonopsis pilosula 20-25 parts, stir-fried Atractylodes macrocephala 18-22 parts, Dendrobium nobile 15-20 parts, Poria cocos 12-15 parts, Smilax china 9-13 parts, Amomum villosum 11-14 parts, Auricularia auricula-judae 7-11 parts, Amomum cardamomum 5-10 parts, and Glycyrrhiza uralensis 3-8 parts.
[0008] Furthermore, a traditional Chinese medicine composition for improving atrophic gastritis is composed of the following raw materials in parts by weight: 22 parts of Codonopsis pilosula, 20 parts of stir-fried Atractylodes macrocephala, 16 parts of Dendrobium nobile, 13 parts of Poria cocos, 10 parts of Angelica sinensis, 13 parts of Amomum villosum, 8 parts of Auricularia auricula-judae, 6 parts of Amomum cardamomum, and 5 parts of Glycyrrhiza uralensis.
[0009] A method for preparing a traditional Chinese medicine composition for improving atrophic gastritis includes the following steps: (1) Mix the crushed and sieved raw materials evenly, add water to soak, and obtain a mixture; (2) Boil the mixture, filter it, and obtain liquid A and dregs; (3) Add water to the dregs obtained in step (2), boil and separate to obtain liquid B. Combine liquid A and liquid B, concentrate under reduced pressure, collect the concentrate, add pharmaceutically acceptable excipients, and make a preparation.
[0010] Further, the mass ratio of the raw material and water in step (1) is 1:8-10, and the mass ratio of the residue and water in step (3) is 1:8-10.
[0011] Furthermore, the decocting time in step (2) is 1.5-3 hours; the decocting time in step (3) is 1.5-3 hours.
[0012] Furthermore, in step (1), the raw material is pulverized and sieved to a mesh size of 50-80.
[0013] Further, in step (3), the concentrate is an extract with a relative density of 1.0-1.2.
[0014] Furthermore, in step (1), the soaking time is 0.5-1h.
[0015] Furthermore, the dosage form of the preparation is any one of tablets, granules, powders, capsules, or oral liquids.
[0016] Codonopsis pilosula: a plant of the Campanulaceae family. Codonopsis pilosula (Franch.) Nannf. Codonopsis pilosula Codonopsis pilosula Nannf. var. modest (Nannf.) LTShen or Sichuan Codonopsis Codonopsis tangshen Oliv.The dried root; its properties and channels: sweet, neutral; enters the spleen and lung channels; has the effects of tonifying the middle and replenishing qi, strengthening the spleen and nourishing the stomach, nourishing blood and generating body fluids, and is mainly used to treat spleen and lung qi deficiency, poor appetite and fatigue, cough and wheezing, qi and blood deficiency, sallow complexion, palpitations and shortness of breath, thirst due to fluid depletion, and internal heat and thirst.
[0017] Stir-fried Atractylodes macrocephala: Atractylodes macrocephala, a plant of the Asteraceae family Atractylodes macrocephala Koidz. The dried rhizome of Atractylodes macrocephala is prepared by stir-frying with wheat bran. The processing method involves sprinkling honey-roasted wheat bran into a hot pan, adding slices of Atractylodes macrocephala after it smokes, and stir-frying until golden brown. Properties and Channels Entered: Bitter, sweet, warm; enters the spleen and stomach channels. Atractylodes macrocephala has the effects of strengthening the spleen and replenishing qi, drying dampness and promoting diuresis, stopping sweating, and calming the fetus. Indications: Used for spleen deficiency with poor appetite, abdominal distension and diarrhea, phlegm retention with dizziness and palpitations, edema, spontaneous sweating, and threatened abortion.
[0018] Dendrobium: Dendrobium nobile, a plant in the Orchidaceae family. Dendrobium nobile Lindl. Dendrobium huoshanense Dendrobium Huoshan's CZ Tang and SJCheng Dendrobium nobile Dendrobium chrysotoxum Lindl. Or Dendrobium fringeii Dendrobium fimbriatum Hook. Fresh or dried stems of cultivated varieties and similar species of the same genus. Properties and Channels Entered: Sweet, slightly cold; enters the Stomach and Kidney channels. Dendrobium has the effects of nourishing the stomach and promoting the production of body fluids, nourishing Yin and clearing heat. It is mainly used to treat febrile diseases with depletion of body fluids, dry mouth and thirst, insufficient stomach Yin, poor appetite and dry retching, persistent low-grade fever after illness, Yin deficiency with exuberant fire, steaming bone fever, blurred vision, and weakness of muscles and bones.
[0019] Poria cocos: a fungus belonging to the Polyporaceae family. Poria cocos (Schw.) Wolf The dried sclerotium of the fungus; its properties and channels: sweet, bland, neutral. It enters the heart, lung, spleen, and kidney channels. It has the effects of promoting diuresis and eliminating dampness, strengthening the spleen, and calming the mind. It is mainly used to treat edema, phlegm retention, spleen deficiency diarrhea, palpitations, and insomnia. Its blandness promotes urination, and its sweetness assists yang, making it an essential medicine for promoting diuresis and eliminating dampness. Its medicinal properties are mild, suitable for both cold and hot, deficiency and excess conditions. Although not a tonic, it has significant effects in strengthening the spleen and replenishing the middle jiao, and is used for spleen deficiency with poor appetite and loose stools. It enters the heart channel and is used for restlessness, palpitations, and insomnia.
[0020] Upside-down plant: A species of fern in the family Asparagaceae, *Acer buergerianum*. Asplenium normal Don The whole plant; can be harvested year-round, washed, dried, or used fresh. Properties and Channels Entered: Slightly bitter in taste, neutral in nature; enters the liver and large intestine channels. It has the effects of clearing heat and detoxifying, and stopping bleeding. Its bitter and neutral nature enters the blood, clearing internal heat and toxins.
[0021] Amomum villosum: Amomum villosum, a plant in the ginger family. Amomum villosum Lour. Green shell sand Amomum villosum Lour. var. xanthioides TL Wu and Senjen Or Hainan Sand Amomum longiligulare TL Wu The dried, ripe fruit of the plant. Properties and channels: pungent, warm; enters the spleen, stomach, and kidney channels. Amomum villosum has the effects of resolving dampness and promoting qi circulation, regulating the middle jiao, harmonizing the stomach, invigorating the spleen, warming the middle jiao to stop diarrhea, and calming the fetus. It is mainly used to treat spleen and stomach qi stagnation, indigestion, abdominal pain and distension, dampness obstructing the middle jiao, spleen and stomach deficiency and cold, vomiting and diarrhea, threatened abortion, and morning sickness.
[0022] Six-eared bell: also known as galloping horse wind, hanging bell yellow; it is the plant *Heliotropium indicum* of the Asteraceae family. Blumea laciniata (Roxb.) DC. [B. sinuata (Lour.) Merr.] The whole plant or leaves. Harvested year-round, used fresh or cut into sections and dried. Properties and Channels Entered: Pungent, bitter, slightly warm. Functions include dispelling wind and dampness, unblocking channels and relieving pain. Indications: Common cold, headache, wind-cold-dampness arthralgia, rheumatoid arthritis swelling and pain, traumatic injuries, carbuncles and boils, eczema, snake bites.
[0023] White cardamom: A plant of the ginger family, specifically white cardamom. I love kravanh Pierre from Gagnep. Or Javanese white cardamom Compact Ammonium Soland from Maton The dried, ripe fruit. Properties and channels: pungent, warm; enters the lung, spleen, and stomach channels. Functions: resolves dampness and promotes qi circulation, warms the middle jiao and stops vomiting, invigorates the stomach and aids digestion. Indications: dampness obstructing the middle jiao, loss of appetite, early stage of damp-heat syndrome, chest tightness and lack of hunger, cold-dampness vomiting, chest and abdominal distension and pain, and indigestion.
[0024] Licorice: is the licorice plant of the legume family. Glycyrrhiza uralensis Fisch licorice root Licorice inflated Bat. Or licorice root Glycyrrhiza glabra L. The dried roots and rhizomes of the plant. Properties and channels: sweet, neutral; enters the heart, lung, spleen, and stomach channels. It has the effects of tonifying the spleen and replenishing qi, clearing heat and detoxifying, resolving phlegm and relieving cough, relieving spasms and pain, and harmonizing other herbs. When roasted, it treats spleen and stomach weakness, poor appetite, abdominal pain and loose stools, fatigue and fever, pulmonary tuberculosis and cough, palpitations, and epilepsy; when used raw, it treats sore throat, peptic ulcers, carbuncles and sores, and detoxifies drug poisoning and food poisoning.
[0025] Compared with the prior art, the main advantages of the present invention are as follows: This invention provides a traditional Chinese medicine composition for improving atrophic gastritis and its preparation method. The composition uses Codonopsis pilosula and stir-fried Atractylodes macrocephala as the principal herbs, which together tonify the middle energizer, strengthen the spleen and stomach, and fundamentally improve the weakness of the spleen and stomach. Dendrobium nobile, Poria cocos, and Artemisia capillaris are used as assistant herbs, which nourish yin and stomach, strengthen the spleen and eliminate dampness, clear heat and detoxify, and relieve stomach heat, while also nourishing stomach yin and removing dampness and toxins. Amomum villosum, Auricularia auricula-judae, and Amomum cardamomum are used as adjuvant herbs, which regulate qi and resolve dampness, unblock meridians and relieve pain, and relieve bloating and vomiting, addressing qi stagnation and dampness obstruction, stomach meridian stagnation, and stomach dysfunction. Glycyrrhiza uralensis is used as the guiding herb to harmonize the other herbs. The entire formula is tonifying without causing stagnation and warming without causing dryness. It tonifies qi and nourishes yin to support the body's resistance, while also resolving stagnation and eliminating dampness to expel pathogens. It can regulate spleen and stomach function holistically, promote the recovery of gastric motility, reduce inflammatory response, regulate gastric mucosal blood flow, and improve the symptoms of atrophic gastritis. The traditional Chinese medicine composition provided by this invention exhibits good compatibility and safety among the herbs. Detailed Implementation
[0026] The technical solution of the present invention will be further described below with reference to specific embodiments. However, those skilled in the art should understand that the following embodiments are only for illustrating the present invention and should not be regarded as limiting the present invention. Specific conditions not specified in the embodiments are performed according to conventional conditions or conditions recommended by the manufacturer. Unless otherwise specified, the reagents or instruments used are all conventional products obtained through commercial channels.
[0027] Example 1 A traditional Chinese medicine composition for improving atrophic gastritis, comprising the following raw materials in parts by weight: 22 parts Codonopsis pilosula, 20 parts stir-fried Atractylodes macrocephala, 16 parts Dendrobium nobile, 13 parts Poria cocos, 10 parts Clematis armandii, 13 parts Amomum villosum, 8 parts Auricularia auricula-judae, 6 parts Amomum villosum, and 5 parts Glycyrrhiza uralensis.
[0028] A method for preparing a traditional Chinese medicine composition for improving atrophic gastritis includes the following steps: (1) Mix the pulverized raw materials (passed through a 60-mesh sieve) evenly according to the weight parts, and then add water at a ratio of 9 times the total weight of the raw materials and soak for 0.6 hours to obtain a mixture; (2) Boil the mixture for 2 hours, then filter the boiled solution with gauze to separate the medicine A and the medicine residue; (3) Add water to the residue obtained in step (2) with a mass ratio of residue to water of 1:9, continue to decoct for 2 hours, separate to obtain liquid B, combine liquid A and liquid B, and then concentrate under reduced pressure at 60°C, collect the concentrate, which is an extract with a relative density of 1.1; dry and pulverize the extract to obtain dry extract powder; add dextrin and sodium carboxymethyl cellulose to the dry extract powder, with the mass of dextrin added being 1% of the dry extract powder and the mass of sodium carboxymethyl cellulose added being 2% of the dry extract powder; mix evenly and then spray granulate to make granules.
[0029] Example 2 A traditional Chinese medicine composition for improving atrophic gastritis, comprising the following raw materials in parts by weight: 20 parts Codonopsis pilosula, 18 parts stir-fried Atractylodes macrocephala, 15 parts Dendrobium nobile, 12 parts Poria cocos, 9 parts Agrimonia pilosa, 11 parts Amomum villosum, 7 parts Auricularia auricula-judae, 5 parts Amomum villosum, and 3 parts Glycyrrhiza uralensis.
[0030] A method for preparing a traditional Chinese medicine composition for improving atrophic gastritis includes the following steps: (1) Mix the pulverized raw materials (passed through a 50-mesh sieve) evenly according to the weight parts, and then add water at 8 times the total weight of the raw materials and soak for 0.5 hours to obtain a mixture; (2) Boil the mixture for 1.5 hours, then filter the boiled solution with gauze to separate the medicine A and the medicine residue; (3) Add water to the residue obtained in step (2) with a mass ratio of residue to water of 1:8, continue to decoct for 1.5 hours, separate to obtain liquid B, combine liquid A and liquid B, and then concentrate under reduced pressure at 60°C, collect the concentrate, which is an extract with a relative density of 1.0; dry and pulverize the extract to obtain dry extract powder; add dextrin and sodium carboxymethyl cellulose to the dry extract powder, with the mass of dextrin being 1.5% of the dry extract powder and the mass of sodium carboxymethyl cellulose being 2% of the dry extract powder; mix evenly and then spray granulate to make granules.
[0031] Example 3 A traditional Chinese medicine composition for improving atrophic gastritis, comprising the following raw materials in parts by weight: Codonopsis pilosula 25 parts, stir-fried Atractylodes macrocephala 22 parts, Dendrobium nobile 20 parts, Poria cocos 15 parts, Smilax china 13 parts, Amomum villosum 14 parts, Auricularia auricula-judae 11 parts, Amomum cardamomum 10 parts, and Glycyrrhiza uralensis 8 parts.
[0032] A method for preparing a traditional Chinese medicine composition for improving atrophic gastritis includes the following steps: (1) Mix the pulverized raw materials (passed through an 80-mesh sieve) evenly according to the weight parts, and then add water with a weight of 10 times the total weight of the raw materials and soak for 1 hour to obtain a mixture; (2) Boil the mixture for 3 hours, then filter the boiled solution with gauze to separate the medicine A and the medicine residue; (3) Add water to the residue obtained in step (2) with a mass ratio of residue to water of 1:10, continue to decoct for 3 hours, separate to obtain liquid B, combine liquid A and liquid B, and then concentrate under reduced pressure at 60°C, collect the concentrate, which is an extract with a relative density of 1.2; dry and pulverize the extract to obtain dry extract powder; add dextrin and sodium carboxymethyl cellulose to the dry extract powder, with the mass of dextrin added being 1.5% of the dry extract powder and the mass of sodium carboxymethyl cellulose added being 1.5% of the dry extract powder; mix evenly and then spray granulate to make granules.
[0033] Comparative Example 1 Comparative Example 1 provides a traditional Chinese medicine composition for improving atrophic gastritis, which is composed of the following raw materials in parts by weight: 22 parts of Codonopsis pilosula, 20 parts of stir-fried Atractylodes macrocephala, 16 parts of Dendrobium nobile, 13 parts of Poria cocos, 13 parts of Amomum villosum, 8 parts of Auricularia auricula-judae, 6 parts of Amomum cardamomum, and 5 parts of Glycyrrhiza uralensis.
[0034] Comparative Example 2 Comparative Example 2 provides a traditional Chinese medicine composition for improving atrophic gastritis, which is composed of the following raw materials in parts by weight: 22 parts of Codonopsis pilosula, 20 parts of stir-fried Atractylodes macrocephala, 16 parts of Dendrobium nobile, 13 parts of Poria cocos, 10 parts of Angelica sinensis, 13 parts of Amomum villosum, 6 parts of Amomum cardamomum, and 5 parts of Glycyrrhiza uralensis.
[0035] Comparative Example 3 Comparative Example 3 provides a traditional Chinese medicine composition for improving atrophic gastritis, which is composed of the following raw materials in parts by weight: 22 parts of Codonopsis pilosula, 20 parts of stir-fried Atractylodes macrocephala, 16 parts of Dendrobium nobile, 13 parts of Poria cocos, 10 parts of Scutellaria barbata, 13 parts of Amomum villosum, 8 parts of Auricularia auricula-judae, 6 parts of Amomum villosum, and 5 parts of Glycyrrhiza uralensis.
[0036] Test case I. Methods for Drug Efficacy Testing 1.1 Experimental Animals: Male SD rats, SPF grade, weighing 160-180g, were selected as experimental animals. The room temperature was maintained at 25℃, and the humidity at 65-70%. The enclosure was kept under alternating light and dark conditions for 12 hours at a time. Clean, dry wood shavings were used as bedding and changed daily. Rats were fed standard feed and had free access to water and food for 7 days to allow for acclimatization.
[0037] 1.2 Construction of an animal model of atrophic gastritis: SD rats were randomly divided into three groups: normal control group, model group, positive drug group, high-dose group of Example 1, medium-dose group of Example 1, low-dose group of Example 1, low-dose group of Example 2, low-dose group of Example 3, low-dose group of Comparative Example 1, low-dose group of Comparative Example 2, and low-dose group of Comparative Example 3, with 10 rats in each group.
[0038] Except for the normal control group, rats were given free access to drinking water containing a 0.04 g / mL solution of N-methyl-N'-nitro-N-nitrosoguanidine. Simultaneously, ranitidine was administered daily via gavage at a dose of 0.03 g / kg. In addition, the rats were subjected to a dysphagia-induced dietary stimulus, specifically alternating between two days of gluten feeding and one day of starvation. All of these interventions were continued for 20 weeks.
[0039] After the intervention, the gastric mucosa of the rats was examined pathologically. If typical pathological changes such as inflammatory cell infiltration and a decrease in the number of gastric glands were observed in the gastric mucosa, the rat model of chronic atrophic gastritis was considered to have been successfully established.
[0040] 1.3 Drug administration Rats with successfully established models were administered the following treatments via gavage: Positive control group: 400 mg / kg / day of Weifuchun capsules administered via gavage for 8 consecutive weeks; High-dose group (Example 1): 12 g / kg / day of the herbal composition prepared in Example 1 administered via gavage for 8 consecutive weeks; Medium-dose group (Example 1): 6 g / kg / day of the herbal composition prepared in Example 1 administered via gavage for 8 consecutive weeks; Low-dose group (Example 1): 3 g / kg / day of the herbal composition prepared in Example 1 administered via gavage for 8 consecutive weeks; Low-dose group (Example 2): 3 g / kg / day of the herbal composition prepared in Example 2 administered via gavage. Rats in the normal control group and model group were given an equal volume of physiological saline by gavage for 8 consecutive weeks. Example 3: Low-dose group: 3g / kg / d of the herbal composition prepared in Example 3 was administered by gavage for 8 consecutive weeks, based on raw medicinal materials. Comparative Example 1: Low-dose group: 3g / kg / d of the herbal composition prepared in Comparative Example 1 was administered by gavage for 8 consecutive weeks, based on raw medicinal materials. Comparative Example 2: Low-dose group: 3g / kg / d of the herbal composition prepared in Comparative Example 2 was administered by gavage for 8 consecutive weeks, based on raw medicinal materials. Comparative Example 3: Low-dose group: 3g / kg / d of the herbal composition prepared in Comparative Example 3 was administered by gavage for 8 consecutive weeks, based on raw medicinal materials.
[0041] 1.4 Indicator Detection Methods 1.4.1 Measurement of Gastric Mucosal Blood Flow: Twelve hours after the last gavage treatment, rats were anesthetized, and the right femoral artery and vein were exposed layer by layer. A catheter was inserted retrogradely into the gastric cavity via the duodenum. Neutral red solution was continuously and slowly infused via the right femoral vein at a dose of 4 mg / kg per hour for 2 hours. Gastric fluid samples were collected every 15 minutes during the experiment. After perfusion, blood was collected from the abdominal aorta of each group of rats, and the neutral red content in gastric fluid and peripheral blood was measured by spectrophotometry. Finally, the gastric mucosal blood flow level of each group of rats was calculated and statistically analyzed according to the formula: Gastric mucosal blood flow = Gastric fluid neutral red concentration / Blood neutral red concentration × Gastric fluid secretion per unit time. The experimental results are shown in Table 1.
[0042] 1.4.2 Measurement of gastric function-related indicators: 12 hours after the last gavage treatment, rats in each group were anesthetized and blood was collected via the abdominal aorta. Serum was obtained by centrifugation at 3000 rpm for 10 min. Following the instructions of the ELISA kit, the levels of pepsinogen I (PGI), gastrin (GAS), and motilin (MTL) in the rat serum were measured using an enzyme-linked immunosorbent assay (ELISA) reader. The results are shown in Table 2.
[0043] 1.4.3 Determination of Inflammatory Factor Levels: Rat stomach tissue was homogenized and centrifuged at 4℃ and 3000 rpm for 10 minutes. The supernatant was collected, and the levels of interleukin-6 (IL-6) and interleukin-1β (IL-1β) in the supernatant were detected using enzyme-linked immunosorbent assay (ELISA) strictly following the manufacturer's instructions. The results are shown in Table 3.
[0044] Table 1 Gastric mucosal blood flow levels in each group of rats Observation Table 1 shows that the gastric mucosal blood flow in the model group was significantly lower than that in the normal control group. Compared with the model group, the gastric mucosal blood flow in the positive drug group and each group in the examples was significantly higher; among them, the high-dose group in Example 1 showed the most significant increase. The improvement effects of the low-dose group in Comparative Example 1 (omitting *Hedyotis diffusa*), the low-dose group in Comparative Example 2 (omitting *Heliotropium indicum*), and the low-dose group in Comparative Example 3 (replacing *Hedyotis diffusa*) were all weaker than those in the low-dose group of Example 1 of this invention, especially the low-dose group in Comparative Example 1, which showed the most significant decrease. This indicates that *Hedyotis diffusa* plays a key role in improving gastric mucosal microcirculation, and *Heliotropium indicum* can be used in combination with it to enhance the therapeutic effect.
[0045] Table 2 Serum gastric function indicators of rats in each group: pepsinogen I, gastrin, and motilin levels. Table 2 shows that the serum levels of PGⅠ, GAS, and MTL in the model group rats were significantly lower than those in the normal control group, indicating gastric gland atrophy and impaired gastric motility and secretion. After intervention, the above indicators in each group of the examples showed varying degrees of recovery. The high-dose group of Example 1 showed the best effect, approaching the level of the normal control group and superior to the positive control group. The recovery rates of the low-dose groups of Comparative Example 1, Comparative Example 2, and Comparative Example 3 were significantly lower than those of the low-dose group of Example 1, indicating that the complete formula of this invention has a synergistic advantage in invigorating qi and strengthening the spleen, and restoring gastric motility, and none of these components can be omitted.
[0046] Table 3. Levels of interleukin-6 and interleukin-1β in rats of each group Table 3 shows that the levels of IL-6 and IL-1β in the gastric tissue of the model group rats were significantly higher than those in the normal control group, indicating significant chronic inflammation of the gastric mucosa. Each group in the examples significantly reduced the levels of inflammatory factors. The high-dose group in Example 1 showed the most prominent anti-inflammatory effect, superior to the positive control group. The low-dose group in Comparative Example 1 had the weakest anti-inflammatory effect, and the low-dose groups in Comparative Example 2 and Comparative Example 3 were also weaker than the low-dose group in Example 1 of this invention. This demonstrates that *Hedyotis diffusa* and *Heliotropium indicum* play an irreplaceable role in inhibiting gastric mucosal inflammation, and the combination of these traditional Chinese medicine compositions can more effectively control inflammation.
[0047] In summary, after intervention with the traditional Chinese medicine compositions in each group of the embodiments of the present invention, the gastric mucosal blood flow of rats in each group showed an increasing trend, the gastric motility level was restored, and the level of inflammatory factors was significantly reduced, indicating that the traditional Chinese medicine compositions of the present invention can regulate the spleen and stomach function and improve the symptoms of atrophic gastritis.
[0048] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them. The basic principles and main features of the present invention have been described above with specific implementation schemes. Based on the present invention, some modifications or substitutions can be made, but these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of protection claimed by the present invention.
Claims
1. A traditional Chinese medicine composition for improving atrophic gastritis, characterized in that, It is composed of the following ingredients in parts by weight: Codonopsis pilosula 20-25 parts, stir-fried Atractylodes macrocephala 18-22 parts, Dendrobium nobile 15-20 parts, Poria cocos 12-15 parts, Gynostemma pentaphyllum 9-13 parts, Amomum villosum 11-14 parts, Auricularia auricula-judae 7-11 parts, Amomum cardamomum 5-10 parts, Glycyrrhiza uralensis 3-8 parts.
2. The traditional Chinese medicine composition for improving atrophic gastritis according to claim 1, characterized in that, It is composed of the following ingredients in parts by weight: Codonopsis pilosula 22 parts, stir-fried Atractylodes macrocephala 20 parts, Dendrobium nobile 16 parts, Poria cocos 13 parts, Smilax china 10 parts, Amomum villosum 13 parts, Auricularia auricula-judae 8 parts, Amomum cardamomum 6 parts, and Glycyrrhiza uralensis 5 parts.
3. A method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 1 or 2, characterized in that, Includes the following steps: (1) Mix the crushed and sieved raw materials evenly, add water to soak, and obtain a mixture; (2) Boil the mixture, filter it, and obtain liquid A and dregs; (3) Add water to the dregs obtained in step (2), boil and separate to obtain liquid B. Combine liquid A and liquid B, concentrate under reduced pressure, collect the concentrate, add pharmaceutically acceptable excipients, and make a preparation.
4. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, The mass ratio of the raw material and water in step (1) is 1:8-10, and the mass ratio of the residue and water in step (3) is 1:8-10.
5. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, The simmering time in step (2) is 1.5-3 hours; the simmering time in step (3) is 1.5-3 hours.
6. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, In step (1), the raw material is pulverized and sieved to a mesh size of 50-80.
7. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, In step (3), the concentrate is an extract with a relative density of 1.0-1.
2.
8. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, In step (1), the soaking time is 0.5-1h.
9. The method for preparing a traditional Chinese medicine composition for improving atrophic gastritis according to claim 3, characterized in that, The dosage form of the preparation mentioned in step (3) is any one of tablets, granules, powders, capsules, or oral liquids.
